Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Metformin price, strengths & recalls

Pharmacies pay $0.44 for 30 tablets of Metformin 500 mg tablet this week, and from $0.44 to $438.15 across its 12 priced strengths and forms. 65 manufacturers make it. It is in shortage (being discontinued). 21 recalls are ongoing. Its official label last changed on June 18, 2026.

Being discontinued21 open recallsGeneric
Pharmacies pay$0.44for 30 tablets of 500 mg tablet+2.2% in 4 weeks
Fair cash price
$11.01
Strengths
12
Makers
65
Updated
Nov 11

Metformin price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
500 mg extended-release tablet$0.2831$8.49 / 30 tablets+4.4%-24.4%
500 mg extended-release tablet$0.1891$5.67 / 30 tablets+15.0%+9.8%
500 mg (24 hr) extended-release tablet$0.0284$0.85 / 30 tablets+0.1%-3.2%
750 mg (24 hr) extended-release tablet$0.0508$1.52 / 30 tablets-3.6%-4.4%
1000 mg extended-release tablet$0.3371$10.11 / 30 tablets+0.4%-32.7%
1000 mg extended-release tablet$0.3116$9.35 / 30 tablets-0.8%+3.2%
100 mg/mL oral solution$0.3590$169.78 / 473 mL-6.3%-45.1%
500 mg tablet$0.0148$0.44 / 30 tablets+2.2%+1.8%
625 mg tablet$12.53$375.80 / 30 tabletsNo change-0.4%
750 mg tablet$14.61$438.15 / 30 tabletsNo changeNo change
850 mg tablet$0.0244$0.73 / 30 tablets+1.8%+8.2%
1000 mg tablet$0.0233$0.70 / 30 tablets+0.7%-1.5%

The lowest cost per tablet is 500 mg tablet at $0.0148. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Supply status: shortages & recalls

In shortage2 products are short or being discontinued
12 ongoing recalls79 recalls on record, latest Apr 16, 2025

Shortages

  • Metformin Hydrochloride, Tablet, Extended Release, 1000 mg (NDC 0378-6001-91)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Oct 22, 2026 · Updated Oct 22, 2026A business decision was made was discontinue manufacture of the drug product.
  • Metformin Hydrochloride, Tablet, Extended Release, 500 mg (NDC 0378-6002-91)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Oct 22, 2026 · Updated Oct 22, 2026A business decision was made was discontinue manufacture of the drug product.

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 79 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for metformin? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 18, 2026
Version7 of 5
EffectiveApr 16, 2026
Read the label

These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995

This drug has a boxed warning

WARNING: LACTIC ACIDOSIS

Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL [see

Warnings and Precautions (5.1)].

Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g. carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, and hepatic impairment, and mitochondrial diseases [see

Warnings and Precautions (5.1)].

Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided [see

Dosage and Administration (2.3), (2.7),

Contraindications (4),

Warnings and Precautions (5.1)].

If metformin-associated lactic acidosis is suspected, immediately discontinue metformin hydrochloride tablets and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended [see

Warnings and Precautions (5.1)].

WARNING: LACTIC ACIDOSIS

See full prescribing information for complete boxed warning.

Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. (

5.1)

Risk factors include renal impairment, concomitant use of certain drugs, age >65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, and hepatic impairment, and mitochondrial diseases. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. (

5.1)

If lactic acidosis is suspected, discontinue metformin hydrochloride tablets and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. (

5.1)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
42 approved generic applications on the market

Metformin questions

How much does metformin cost without insurance?

Pharmacies pay about $0.44 for 30 tablets of metformin 500 mg tablet ($0.0148 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $11.01. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is metformin in shortage?

Yes. 2 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has metformin been recalled?

79 recalls on record, 21 ongoing. Recalls name specific lots - check yours.

When did the metformin label last change?

The official label was last updated on June 18, 2026 (version 7). See what changed.

Talk about metformin

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.